Business Context and Reporting Period
This Form 8-K reports on the results of NextCure, Inc.'s 2021 Annual Meeting of Stockholders held on June 24, 2021. The company is an emerging growth company incorporated in Delaware with its principal executive offices in Beltsville, Maryland.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two primary proposals:
- Proposal No. 1: Election of Class II Directors
- Ellen V. Jones, Ph.D.: Elected with 15,606,215 votes For, 2,167,379 Against, and 13,993 Abstain. Broker non-votes totaled 4,303,808.
- Chau Q. Khuong: Elected with 16,317,616 votes For, 1,456,078 Against, and 13,893 Abstain. Broker non-votes totaled 4,303,808.
- Both directors were elected to serve three-year terms expiring at the 2024 Annual Meeting.
- Proposal No. 2: Ratification of Independent Registered Public Accounting Firm
- Stockholders ratified the appointment of Ernst & Young LLP for the fiscal year ending December 31, 2021.
- Voting results: 21,953,903 For, 11,361 Against, and 126,131 Abstain. There were no broker non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirmation that Ellen V. Jones, Ph.D., and Chau Q. Khuong have officially joined the Board of Directors.
- Verification of the significant number of broker non-votes (4,303,808) regarding the director elections, indicating shares held by brokers without voting instructions on these matters.
- Confirmation that Ernst & Young LLP remains the independent auditor for the 2021 fiscal year.